On May 1, 2019, the Louisiana Department of Corrections (DOC) launched an addiction treatment pilot program which includes a long-acting naltrexone implant that can last for multiple months and can vary by individual. The pilot will make up to 10 programs, inclusive of the implant, cognitive behavioral therapy (CBT), and peer support, available to volunteers preparing for release for the treatment of alcohol and opioid use disorders. The implant portion of the program is provided from a licensed compounding pharmacy using one of BioCorRx, Inc.’s formulas, and is to demonstrate the cost and social benefit of using the . . .